EXHIBIT 99.1

OPHTHALMIC IMAGING SYSTEMS SIGNS CONTRACT WITH HENRY FORD HEALTH SYSTEM

OIS TO UPGRADE OPHTHALMOLOGY DEPARTMENTS IN 15 HFHS LOCATIONS

Sacramento,  California,  February 1, 2006-- Ophthalmic  Imaging Systems ("OIS")
(OTCBB:OISI - News), a leading  provider of ophthalmic  digital imaging systems,
announced  today a $548,000  contract  with Henry Ford Health  System  (HFHS) to
upgrade the  ophthalmology  departments in 15 HFHS locations to fully integrated
digital systems.

Under the terms of the agreement,  scheduled for completion in the first half of
2006, OIS will implement two key upgrades to the HFHS  ophthalmology  department
system.  The  first  step in the  process  will  be to  convert  the  film-based
ophthalmic  photography  systems to digital imaging  systems.  This will include
modifying  existing  stations and deploying new digital  capture  stations.  The
second step will employ a completely  automated  interface system throughout the
ophthalmic  department  allowing  automated  import of objects from a variety of
existing  and  future  ophthalmic  diagnostic  equipment,  including  OCT,  HFA,
Ultrasound, Topography, HRT, SLO, to a single platform.

Once  operational,   the  system  will  be  completely   integrated  with  HFHS'
infrastructure,   including  image  acquisition,   image  analysis,  short-  and
long-term storage,  archiving,  disaster recovery, viewing, and monitoring. HFHS
also  entered  contracts  with other  vendors  for IT hardware  and  integration
upgrades related to the systems upgrade for approximately $700,000.

"OIS is at the front of the technology curve in bringing the Ophthalmology field
to the  digital  age.  We are  pleased  Henry Ford  Health  System has chosen to
partner with OIS in upgrading its ophthalmology  department,"  stated Gil Allon,
CEO of Ophthalmic  Imaging Systems.  "Our digital imaging  products  continue to
offer superior quality compared to film and our software  platform has created a
more user-friendly environment for both diagnosis and storage."

Paul A. Edwards,  M.D., chair Department of Ophthalmology,  Eye Care Services of
Henry Ford  Health  System,  stated,  "We are excited to take this next step and
look forward to building a strong  relationship with OIS as we move forward with
the  implementation  of our new system.  We  recognize  the  advancements  which
digital  imaging  has made in health  care over the past few years and feel that
digital's  high  resolution,  storage and access  capabilities  will advance our
environment  well into the future.  OIS'  comprehensive  network  will offer our
physicians the convenience of having patient data readily  available from a wide
array of tests and devices to help diagnose and monitor patients."

About Henry Ford Health

System  Henry  Ford  Health  System  (www.henryford.com),  one of the  country's
leading health care systems, integrates primary and specialty care with research
and  education.  It includes  Henry Ford  Hospital  and six owned or  affiliated
hospitals; Health Alliance Plan, a 530,000 member



HMO; the 900 physician/scientist Henry Ford Medical Group, 24 ambulatory centers
and other health-related services located throughout southeastern Michigan.

About Ophthalmic Imaging Systems

Ophthalmic  Imaging  Systems  (www.oisi.com),  a  majority-owned  subsidiary  of
MediVision,  is the leading provider of ophthalmic digital imaging systems.  The
Company designs, develops,  manufactures and markets digital imaging systems and
informatics  solutions  for the eye care  market.  With over twenty years in the
ophthalmic  imaging  business,  the Company  has  consistently  introduced  new,
innovative  technology.  The Company,  together with  MediVision,  co-market and
support their products  through an extensive  network of dealers,  distributors,
and direct representatives.

Statements   in  this  press  release   which  are  not   historical   data  are
forward-looking statements which involve known and unknown risks, uncertainties,
or other  factors  not  under the  Company's  control,  which  may cause  actual
results,  performance, or achievements of the Company to be materially different
from  the  results,   performance,   or  other  expectations  implied  by  these
forward-looking statements. These factors include, but are not limited to, those
detailed in the  Company's  periodic  filings with the  Securities  and Exchange
Commission.

Contact:
Ophthalmic Imaging Systems
Gil Allon, 916-646-2020
Ariel Shenhar, 916-646-2020
 or
KCSA Worldwide
Todd Fromer, 212-896-1215 (Investor Relations)
Garth Russell, 212-896-1250 (Investor Relations)